Verquvo vs Entresto, choosing between Verquvo and Entresto depends on your specific heart failure history. Verquvo is a once-daily pill best for patients who have recently worsened or been hospitalized, while Entresto is a twice-daily first-line option for stable heart failure. Your doctor in will decide based on your symptoms, kidney function, and blood pressure.
If you or someone you love is managing heart failure, you have likely heard the names Verquvo and Entresto. Verquvo vs Entresto is a common question that comes up during doctor visits. Both medications help people with heart failure feel better and live longer. But they work in different ways. Knowing the difference can help you talk to your doctor and make the best choice for your health.
Heart failure is a serious condition. It means your heart does not pump blood as well as it should. But there is good news. New medications like Verquvo and Entresto are changing how heart failure is treated. These drugs are available through various hospitals and pharmacies. In this segment I will break down everything you need to know about these two options.
What Is Heart Failure and Why Do You Need Treatment?
Before we compare Verquvo vs Entresto, let us understand what you are treating. Heart failure does not mean your heart stops. It means your heart is weak. It cannot pump enough blood to meet your body’s needs. You may feel tired. You may get short of breath. Your legs might swell.
Doctors prescribe medications to help your heart work better. These drugs reduce your symptoms. They also help you stay out of the hospital. The right medication can give you more years and more good days.
Now, let us look at each medication one by one.
What Is Verquvo?
Verquvo is the brand name for a drug called vericiguat . It belongs to a new class of medications called soluble guanylate cyclase (sGC) stimulators. That is a big name. But here is what you need to know. Verquvo helps your blood vessels relax. It helps your heart pump more easily.
Your doctor might prescribe Verquvo if you have chronic heart failure. It is for people who have had a recent hospital stay for heart failure. It is also for people who needed IV medications to help their heart . If your heart failure is getting worse, Verquvo could be an option.
How Do You Take Verquvo?
You take Verquvo as a tablet. The good news is you only take it once a day . That makes it easy to remember. You can crush the tablet and mix it with water if you have trouble swallowing pills . This is helpful for older patients.
What Are the Side Effects of Verquvo?
All medications have side effects. With Verquvo, the most common side effects are low blood pressure and anemia . Anemia means your red blood cell count drops. You might feel tired or pale. Your doctor will monitor you for these issues.
Who Should Not Take Verquvo?
Verquvo is not safe during pregnancy. It can harm an unborn baby . It is also not approved for children . If you are pregnant or planning to become pregnant, tell your doctor.
What Is Entresto?
Entresto is another name you will hear often. It is a combination drug. It contains sacubitril and valsartan . This type of drug is called an ARNI. That stands for angiotensin receptor-neprilysin inhibitor.
Entresto does two things. It helps your blood vessels relax. It also blocks harmful chemicals that make heart failure worse. Entresto is often a first-choice treatment for many people with heart failure . It has been around longer than Verquvo. Many doctors are familiar with it.
How Do You Take Entresto?
You take Entresto twice a day . It comes as tablets. There is also a sprinkle form for people who have trouble swallowing. You open the capsule and mix the pellets with soft food . This is good for children or older adults.
What Are the Side Effects of Entresto?
Common side effects include low blood pressure and dizziness. Some people get a cough. A more serious side effect is angioedema. That is swelling of the face, tongue, or throat . If you have trouble breathing, get help right away. Entresto can also affect your kidneys and raise your potassium levels . Your doctor will do blood tests to monitor you.
Who Should Not Take Entresto?
Like Verquvo, Entresto is not safe during pregnancy . It can harm your baby. If you have had angioedema before, you might need to avoid Entresto. Always tell your doctor your full medical history.
Verquvo vs Entresto: Head-to-Head Comparison
Now we get to the heart of the matter. How do these two drugs stack up against each other? Here is a simple breakdown.
How They Work
Verquvo stimulates an enzyme that helps your blood vessels relax. Entresto blocks harmful chemicals and helps your body retain good ones. They take different paths to a similar goal. Both aim to reduce the strain on your heart.
Dosing Frequency
Verquvo is once daily. Entresto is twice daily . If you have trouble remembering to take medicine, once a day might be easier. But if you are already taking other twice-daily medications, Entresto might fit your routine.
Who They Are For
Verquvo is for people with worsening heart failure. It is for those who have recently been in the hospital or needed IV meds . Entresto is used more broadly. It is for adults and also children as young as one year old .
Cost Considerations
Both are brand-name medications. As of early 2025, there is no generic version of either drug . That means they can be expensive. Prices vary between hospitals and pharmacies. Some facilities offer payment plans. You should check with your insurance provider to see what is covered.
Side Effect Profiles
Both can cause low blood pressure. Verquvo is linked to anemia . Entresto carries a risk of angioedema and high potassium . Your doctor will consider your other health conditions when choosing.
Which One Is Better for You?
This is the question you really want answered. There is no one-size-fits-all answer. The choice between Verquvo vs Entresto depends on your unique situation.
Factors Your Doctor Will Consider
Your doctor will look at several things. How severe is your heart failure? Have you been in the hospital recently? Do you have kidney problems? Do you have low blood pressure already?
If you have stable heart failure, Entresto is often the first choice . It has a strong track record. If you are getting worse despite other treatments, Verquvo might be added .
Some patients actually take both. That is right. Verquvo and Entresto can be used together in some cases. They work through different pathways. Combining them might give you more benefit.
Talking to Your Cardiologist
Do not try to choose on your own. Heart failure medications are powerful. You need a specialist to guide you. There are excellent cardiologists at hospitals like Aga Khan University Hospital and Hospital. They can run tests and make recommendations.
When you see your doctor, ask questions. How will this drug help me? What side effects should I watch for? How will we know if it is working?
How to Access These Medications
Getting these medications is possible but requires planning. They are not over-the-counter drugs. You need a prescription.
Where to Find Verquvo and Entresto
Major hospitals stock these medications. You can check at Aga Khan University Hospital, Nairobi Hospital, or M.P. Shah Hospital. Some retail pharmacies like Goodlife Pharmacy or Medplus may also have them. It is a good idea to call ahead to confirm availability.
Managing Costs
These are expensive drugs. But there are ways to manage the cost. Some insurance plans cover heart failure medications. Check with your insurer. Some hospitals offer discounts or payment plans. You can also ask your doctor if there are patient assistance programs available in Kenya.
Lifestyle Tips for Heart Failure Management
Medications like Verquvo and Entresto are powerful. But they work best when you also make lifestyle changes. Here are some tips.
Watch Your Salt
Too much salt makes your body hold water. That puts more strain on your heart. Avoid adding salt to food. Stay away from processed foods like sausages and canned goods. Cook fresh food at home when you can.
Monitor Your Weight
Weigh yourself every morning. If you gain two or three kilograms in a few days, call your doctor. That could mean your body is holding fluid. Your medication dose might need adjustment.
Stay Active
You do not need to run a marathon. Gentle walking is good. Ask your doctor what level of activity is safe for you. Exercise helps your heart stay strong.
Take Your Medications
This is critical. Take your Verquvo or Entresto exactly as prescribed. Do not skip doses. If you have side effects, talk to your doctor. Do not just stop taking the drug. Stopping suddenly can make your heart failure worse.
Questions to Ask Your Doctor
When you go for your next appointment, write down these questions. Take them with you.
- Which medication is better for me, Verquvo or Entresto?
- Can I take both together?
- How will we monitor my kidney function and blood pressure?
- What side effects should I call you about right away?
- How much will this cost, and do you know any assistance programs?
The Future of Heart Failure Treatment
The world of heart failure treatment is moving fast. Drugs like Verquvo represent new hope . They target different parts of the disease process. In the coming years, we may see even more options. For now, Verquvo vs Entresto gives you two strong choices.
Living Well With Heart Failure
A diagnosis of heart failure is serious. But it is not the end. Many people live full, active lives with the right treatment. They travel. They spend time with family. They pursue their hobbies.
The key is to take your medications, see your doctor regularly, and take care of yourself. You have the power to manage this condition. It does not have to manage you.
Summary
Verquvo vs Entresto: Complete Comparison Table
| Feature | Verquvo (Vericiguat) | Entresto (Sacubitril/Valsartan) |
|---|---|---|
| Drug Class | Soluble Guanylate Cyclase (sGC) Stimulator | Angiotensin Receptor-Neprilysin Inhibitor (ARNI) |
| Mechanism of Action | Stimulates sGC enzyme to increase cyclic GMP, leading to vasodilation and reduced cardiac fibrosis | Inhibits neprilysin (increasing natriuretic peptides) and blocks angiotensin II receptors for dual vasodilation |
| FDA Approval Date | January 2021 | July 2015 |
| Indication | Chronic heart failure with reduced ejection fraction (HFrEF) in patients with worsening heart failure after a recent hospitalization or need for IV diuretics | Chronic heart failure with reduced ejection fraction (HFrEF) in adults and pediatric patients aged 1 year and older |
| Dosage Forms | 2.5 mg, 5 mg, 10 mg tablets | 24 mg/26 mg, 49 mg/51 mg, 97 mg/103 mg tablets; Sprinkle capsules for oral suspension |
| Dosing Frequency | Once daily | Twice daily (approximately 12 hours apart) |
| Starting Dose | 2.5 mg once daily | 24 mg/26 mg twice daily or 49 mg/51 mg twice daily depending on prior medication history |
| Target Maintenance Dose | 10 mg once daily | 97 mg/103 mg twice daily |
| Titration Schedule | Double dose every 2 weeks based on blood pressure and tolerance | Double dose every 2 to 4 weeks based on blood pressure, renal function, and potassium levels |
| Food Interaction | Can be taken with or without food | Can be taken with or without food |
| Administration for Swallowing Difficulty | Tablet can be crushed and mixed with water | Sprinkle capsules can be opened and mixed with soft food (applesauce, yogurt) |
| Most Common Side Effects | Hypotension (low blood pressure), anemia | Hypotension, hyperkalemia (high potassium), renal impairment, cough, dizziness |
| Serious Side Effects | Symptomatic hypotension, severe anemia | Angioedema (swelling of face/lips/tongue/throat), acute kidney injury, hyperkalemia requiring intervention |
| Black Box Warning | None | None (though fetal toxicity warning exists) |
| Pregnancy Category | Contraindicated. May cause fetal harm. | Contraindicated. Direct renin-angiotensin system action can cause fetal harm. |
| Breastfeeding | Not recommended. Unknown if excreted in human milk. | Not recommended. Unknown if excreted in human milk. |
| Pediatric Use | Safety and effectiveness not established in children | Approved for pediatric patients aged 1 year and older |
| Geriatric Use | No dose adjustment needed based on age alone | No overall differences in safety or effectiveness observed |
| Renal Impairment | No dose adjustment for mild to moderate impairment. Not studied in severe impairment (eGFR <15 mL/min/1.73m²) | Dose adjustment required. Not recommended for severe impairment (eGFR <30 mL/min/1.73m²) |
| Hepatic Impairment | No dose adjustment for mild to moderate impairment. Not studied in severe impairment | Not recommended for severe hepatic impairment (Child-Pugh Class C) |
| Drug Interactions | Avoid with other sGC stimulators. Use caution with PDE-5 inhibitors (may increase hypotensive effect) | Avoid with ARBs, ACE inhibitors, aliskiren in diabetes, and NSAIDs (increased renal risk). Do not use with ACE inhibitors within 36 hours |
| Washout Period | No specific washout required | Must stop ACE inhibitors 36 hours before starting Entresto |
| Monitoring Requirements | Blood pressure, hemoglobin levels, signs of bleeding | Blood pressure, serum potassium, renal function (creatinine), signs of angioedema |
| Cost in Nairobi | High (brand only, no generic) | High (brand only, no generic as of 2025) |
| Availability in Nairobi | Available at major hospitals and select pharmacies | Widely available at major hospitals and retail pharmacies |
| Insurance Coverage | Varies by insurer; may require prior authorization | Varies by insurer; often covered with prior authorization |
| Patient Assistance Programs | Limited in Kenya; inquire with prescribing hospital | Limited in Kenya; some global programs may apply |
| Clinical Trial Evidence | VICTORIA trial (2020): Reduced cardiovascular death or heart failure hospitalization in worsening heart failure patients | PARADIGM-HF trial (2014): Superior to enalapril in reducing cardiovascular death and heart failure hospitalization |
| Number Needed to Treat (NNT) | NNT of 24 to prevent one primary outcome event over 1 year | NNT of 21 to prevent one cardiovascular death or heart failure hospitalization over 2.5 years |
| Use in Combination | Can be used alongside Entresto, beta-blockers, diuretics, and mineralocorticoid antagonists | Can be used alongside Verquvo, beta-blockers, diuretics, and mineralocorticoid antagonists |
| Contraindications | Concomitant use with other sGC stimulators | Concomitant use with ACE inhibitors (within 36 hours), history of angioedema with ARBs or ACE inhibitors, concomitant aliskiren in diabetes |
| Manufacturer | Bayer and Merck & Co. | Novartis |
| Patent Expiry | 2032 (US) | 2025–2027 depending on region |
Verquvo vs Entrest 5 Most Asked Questions
1. Can I take Verquvo and Entresto together?
Yes, you can. Doctors sometimes prescribe both medications together because they work through different pathways. Verquvo helps blood vessels relax through one mechanism, while Entresto works through another. Taking both may give you added protection. However, you must only do this under close supervision from your cardiologist, as the combination can lower your blood pressure more than either drug alone.
2. Which one is safer for my kidneys?
Entresto requires more caution if you have kidney problems. It can raise your creatinine levels and affect kidney function. Your doctor will monitor your kidneys closely with regular blood tests. Verquvo does not have the same direct effect on the kidneys. If you have severe kidney impairment, your doctor may prefer Verquvo or adjust your Entresto dose carefully.
3. Which medication is more affordable in Nairobi?
Both are brand-name medications with no generic versions available yet. Prices vary between hospitals and pharmacies. Generally, Entresto has been on the market longer and may have more established pricing structures. Some insurance plans cover Entresto more readily. Verquvo is newer and may require prior authorization from your insurer. Always call ahead to check prices at Aga Khan University Hospital, Nairobi Hospital, and major pharmacies like Goodlife Pharmacy.
4. What happens if I miss a dose?
For Verquvo, take it as soon as you remember on the same day. If you do not remember until the next day, skip the missed dose and take your next dose at the regular time. Do not take two doses at once.
For Entresto, if you miss a dose by less than 6 hours, take it right away. If more than 6 hours have passed, skip it and take your next dose at the regular time. Twice-daily medications are harder to catch up on, so setting a daily alarm helps.
5. How long will I need to take these medications?
Heart failure is a chronic condition. You will likely take your medication for life. These drugs manage your symptoms and protect your heart from further damage. They are not a cure. Stopping them suddenly can cause your heart failure to worsen quickly. Always talk to your doctor before making any changes. Many patients stay on these medications for years with good quality of life.
Key Takeaway
We have covered a lot. Verquvo vs Entresto is an important question. Verquvo is a once-daily option for worsening heart failure. Entresto is a twice-daily drug that is often a first-line treatment. Both have side effects. Both require a prescription and careful monitoring.
Talk to your cardiologist. Bring your questions. Be honest about your symptoms and your lifestyle. Together, you can decide which medication fits your life and your health goals.
You are not alone on this journey. Heart failure is common, and treatments are better than ever. Take the first step today. Schedule that appointment. Start the conversation. Your heart will thank you. Find more helpful medical content from the Medical Antidote